Drug reference
amikacin liposome inhalation suspension
Antimycobacterial agent, Aminoglycoside, Liposomal formulation. Amikacin Liposome Inhalation Suspension (ALIS) is a novel formulation of the aminoglycoside amikacin designed for improved lung penetrat
Antimycobacterial agent, Aminoglycoside, Liposomal formulation. Amikacin Liposome Inhalation Suspension (ALIS) is a novel formulation of the aminoglycoside amikacin designed for improved lung penetrat
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Related guidelines
Other Unclassified drugs
Ask House about amikacin liposome inhalation suspension
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team